The global biochip products and services sector is poised for an exciting transformation as we approach 2033. This remarkable growth is fueled by an increasing demand for personalized medicine, cutting-edge genomic and proteomic analyses, and the urgent need for rapid diagnostics to tackle chronic and infectious diseases. Innovative technologies are at the forefront of this growth. Microarrays,...